Spleen lymphocyte populations and expression of activation markers in rats treated with the potent new immunosuppressive agent FK-506
- PMID: 2460401
- PMCID: PMC1385035
Spleen lymphocyte populations and expression of activation markers in rats treated with the potent new immunosuppressive agent FK-506
Abstract
Rats were immunized systemically with sheep red blood cells (SRBC) and treated with either FK-506 (1 mg/kg/day) or cyclosporin A (CsA) (25 mg/kg/day) for 7 days. Profound (greater than 90%) suppression of the production of splenic IgM-secreting plasma cells and circulating antibody levels was observed in animals receiving either drug. Immunosuppression was accompanied by significant increases in the incidence and absolute numbers of OX8+ (T-cytotoxic/suppressor) lymphocytes in the spleen, and there were corresponding reductions in the W3/25+:OX8 (CD4+:CD8+) ratio. The magnitude of these changes was not affected by drug combination. There were no significant alterations in B cells with either agent, whilst a small but significant increase in the incidence of macrophages was observed in all drug-treated groups. Neither FK-506 nor CsA affected IL-2 receptor (OX39) or MHC class II (OX6) antigen expression. This study demonstrates the remarkable immunosuppressive potency of FK-506 and its underlying capacity, like CsA, to affect regulatory T-lymphocyte subsets in vivo.
Similar articles
-
Immunosuppressive activity of FK-506 in rats: flow cytometric analysis of lymphocyte populations in blood, spleen and thymus during treatment and following drug withdrawal.Clin Exp Immunol. 1990 Jan;79(1):109-14. doi: 10.1111/j.1365-2249.1990.tb05136.x. Clin Exp Immunol. 1990. PMID: 1689226 Free PMC article.
-
Augmentation of delayed-type hypersensitivity to high dose sheep erythrocytes by cyclosporin A in the mouse: influence of drug dosage and route of administration and analysis of spleen cell populations.Clin Exp Immunol. 1988 Jan;71(1):149-54. Clin Exp Immunol. 1988. PMID: 3349644 Free PMC article.
-
Immunosuppressive activity, lymphocyte subset analysis, and acute toxicity of FK-506 in the rat. A comparative and combination study with cyclosporine.Transplantation. 1989 Jan;47(1):60-5. doi: 10.1097/00007890-198901000-00014. Transplantation. 1989. PMID: 2463701
-
Cyclosporine and the immune response: basic aspects.Crit Rev Immunol. 1986;6(2):123-49. Crit Rev Immunol. 1986. PMID: 2942335 Review.
-
FK-506--how much potential?Immunol Today. 1989 Jan;10(1):6-9. doi: 10.1016/0167-5699(89)90057-1. Immunol Today. 1989. PMID: 2473767 Review.
Cited by
-
Immunosuppressive activity of FK-506 in rats: flow cytometric analysis of lymphocyte populations in blood, spleen and thymus during treatment and following drug withdrawal.Clin Exp Immunol. 1990 Jan;79(1):109-14. doi: 10.1111/j.1365-2249.1990.tb05136.x. Clin Exp Immunol. 1990. PMID: 1689226 Free PMC article.
-
The efficacy of cyclosporin A, FK-506 and prednisolone to modify the adoptive transfer of experimental allergic encephalomyelitis (EAE).Agents Actions. 1992 Jan;35(1-2):79-84. doi: 10.1007/BF01990955. Agents Actions. 1992. PMID: 1380765
-
Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.Drugs. 1993 Oct;46(4):746-94. doi: 10.2165/00003495-199346040-00009. Drugs. 1993. PMID: 7506654 Review.
-
Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506.Immunology. 1989 Aug;67(4):473-7. Immunology. 1989. PMID: 2475433 Free PMC article.
-
Inhibition of murine B-lymphocyte proliferation by the novel immunosuppressive drug FK-506.Immunology. 1989 Nov;68(3):434-5. Immunology. 1989. PMID: 2480331 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials